These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28118059)

  • 21. [Female sexual dysfunction as adverse effect of pharmacological treatment].
    Giraldi AG; Victor J
    Ugeskr Laeger; 2002 Oct; 164(41):4757-60. PubMed ID: 12407875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of androgens in hormone replacement therapy.
    Johnson CE; Berman JR
    Expert Opin Pharmacother; 2005 Sep; 6(11):1815-31. PubMed ID: 16144503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women.
    Kushnir VA; Darmon SK; Barad DH; Weghofer A; Gleicher N
    Endocrine; 2019 Mar; 63(3):632-638. PubMed ID: 30311171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effects of Herbal Medicines on Women Sexual Dysfunction: A Systematic Review.
    Molkara T; Motavasselian M; Akhlaghi F; Ramezani MA; Naghedi Baghdar H; Ghazanfari SM; Salari R
    Curr Drug Discov Technol; 2021; 18(6):e130921186972. PubMed ID: 33076811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review.
    Peixoto C; Devicari Cheda JN; Nardi AE; Veras AB; Cardoso A
    Curr Drug Targets; 2014; 15(9):901-14. PubMed ID: 25039497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety of 52 weeks of oral DHEA therapy for postmenopausal women.
    Panjari M; Bell RJ; Jane F; Adams J; Morrow C; Davis SR
    Maturitas; 2009 Jul; 63(3):240-5. PubMed ID: 19410392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B; Apaydin E; Semerci B; Altay B; Cikili N; Nazli O
    Int J Impot Res; 2005; 17(2):148-53. PubMed ID: 15592425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between sexual hormones, quality of life and postmenopausal sexual function.
    Peixoto C; Carrilho CG; Ribeiro TTSB; da Silva LM; Gonçalves EA; Fernandes L; Nardi AE; Cardoso A; Veras AB
    Trends Psychiatry Psychother; 2019 May; 41(2):136-143. PubMed ID: 31166564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects.
    Zimmerman Y; Foidart JM; Pintiaux A; Minon JM; Fauser BC; Cobey K; Coelingh Bennink HJ
    Contraception; 2015 Feb; 91(2):134-42. PubMed ID: 25496917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
    Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():177-8. PubMed ID: 18783531
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacotherapy for women's sexual dysfunction.
    Basson R
    Expert Opin Pharmacother; 2009 Jul; 10(10):1631-48. PubMed ID: 19527189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.
    Elraiyah T; Sonbol MB; Wang Z; Khairalseed T; Asi N; Undavalli C; Nabhan M; Altayar O; Prokop L; Montori VM; Murad MH
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3536-42. PubMed ID: 25279571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Summary of the recommendations on sexual dysfunctions in women.
    Basson R; Wierman ME; van Lankveld J; Brotto L
    J Sex Med; 2010 Jan; 7(1 Pt 2):314-26. PubMed ID: 20092441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in pharmacotherapy for treating female sexual dysfunction.
    Nappi RE; Cucinella L
    Expert Opin Pharmacother; 2015 Apr; 16(6):875-87. PubMed ID: 25732267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Flibanserin Meaningfully Superior to Placebo?
    Clayton AH; Pyke RE
    J Sex Marital Ther; 2017 Apr; 43(3):218-222. PubMed ID: 28075707
    [No Abstract]   [Full Text] [Related]  

  • 37. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results.
    Munarriz R; Talakoub L; Flaherty E; Gioia M; Hoag L; Kim NN; Traish A; Goldstein I; Guay A; Spark R
    J Sex Marital Ther; 2002; 28 Suppl 1():165-73. PubMed ID: 11898698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ovariectomy and dehydroepiandrosterone (DHEA) on vaginal wall thickness and innervation.
    Pelletier G; Ouellet J; Martel C; Labrie F
    J Sex Med; 2012 Oct; 9(10):2525-33. PubMed ID: 22905785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen.
    Simon JA
    J Womens Health (Larchmt); 2011 Oct; 20(10):1453-65. PubMed ID: 21819250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
    Nathorst-Böös J; Flöter A; Jarkander-Rolff M; Carlström K; Schoultz Bv
    Maturitas; 2006 Jan; 53(1):11-8. PubMed ID: 16183220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.